文献速递创伤与烧伤儿科与产科急症

儿童创伤内皮病:syndecan-1与损伤及不良结局的关联

Endotheliopathy of trauma in children: The association of syndecan-1 with injury and poor outcomes.
PubMed 文献 · J Trauma Acute Care Surg · 2023-12-08
一句话结论儿童创伤后入院时syndecan-1升高提示内皮病,与休克和不良结局(死亡或输血)相关,每升高10 ng/mL死亡或输血 odds 增加10%。

这项前瞻性队列研究纳入121名因疑似严重创伤就诊于学术性儿童创伤中心的18岁以下儿童,其中96名(79%)为受伤组、25名(21%)为未受伤组。入院时syndecan-1中位数受伤组显著高于未受伤组(44 vs 25 ng/mL,p=0.04),入院碱缺失与syndecan-1显著相关(r=0.8,p<0.001)。syndecan-1每升高10 ng/mL,死亡或24小时内输血复合结局的 odds 增加10%(p<0.001)。作者认为需更大规模队列研究以全面描述创伤诱导凝血病并探索针对内皮病的治疗获益。

要点

  • 儿童严重创伤入院时syndecan-1中位数显著高于未受伤儿童(44 vs 25 ng/mL,p=0.04),提示内皮病。
  • 入院碱缺失与syndecan-1水平显著相关(r=0.8,p<0.001),但未发现与创伤性脑损伤或损伤机制的关联。
  • syndecan-1每升高10 ng/mL,死亡或24小时内输血的 odds 增加10%(p<0.001)。
  • 接受任何血制品输注者从入院到24小时syndecan-1下降幅度更大(Δ -17 vs -8,p<0.0001)。
  • 受伤组中位损伤严重度评分16(9-21),75%为钝性机制,26%在6小时内输血,24小时死亡率3%,院内死亡率6%。

适用人群与场景

  • 18岁以下儿童,因疑似严重创伤就诊于学术性儿童创伤中心(前瞻性队列)。受伤组为经创伤评估确认受伤者(96/121,79%),未受伤组为评估后未受伤者(25/121,21%)。

诊断标准与关键阈值

  • 受伤与未受伤基于创伤评估结果分类。
  • 复合临床结局定义为入院后24小时内死亡或输注血制品。
  • syndecan-1于入院时及入院后24小时采集。

研究设计与关键结果

  • 前瞻性队列研究,共121名儿童:受伤96名(79%),未受伤25名(21%);组间年龄(中位11岁,IQR 4-14)、性别、种族无差异。
  • 受伤组中位损伤严重度评分16(IQR 9-21),75%为钝性机制,26%在6小时内输血,24小时死亡率3%,院内死亡率6%。
  • 入院syndecan-1中位数受伤组显著高于未受伤组(44 [IQR 21-75] vs 25 [IQR 17-42] ng/mL,p=0.04)。
  • 入院碱缺失与syndecan-1显著相关(r=0.8,p<0.001);未发现与创伤性脑损伤或损伤机制的关联。
  • 入院syndecan-1升高与不良结局 odds 增加相关;每升高10 ng/mL,死亡或输血的 odds 增加10%(p<0.001)。
  • 接受任何血制品输注者从入院到24小时syndecan-1下降更明显(Δ -17 [IQR -64至-5] vs -8 [IQR -19至+2],p<0.0001)。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究;证据等级:预后与流行病学,Level III。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为需更大规模队列研究以全面描述创伤诱导凝血病的复杂性,并研究针对儿童内皮病的治疗获益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The contribution of the endothelium to trauma-induced coagulopathy has not been thoroughly investigated in injured children.

METHODS: This is a prospective cohort study of children (younger than 18 years) who presented with a potentially severe injury to an academic pediatric trauma center. Syndecan-1 level was collected on arrival and 24 hours following hospital arrival. Children were categorized as injured versus uninjured based on results of trauma evaluation. Demographics, injury characteristics, vital signs, and clinical laboratories were recorded. A composite clinical outcome was defined as death or blood product transfusion within 24 hours of hospital arrival. Statistical tests determined the impact of injury characteristics and therapeutics on syndecan-1 levels and assessed for associations between syndecan-1 level and outcomes.

RESULTS: A total of 121 subjects were included in the analysis: 96 injured (79%) and 25 uninjured (21%). There were no differences between groups in age (median [interquartile range (IQR)], 11 [4-14] years), sex, or race. The injured cohort had a median (IQR) Injury Severity Score of 16 (9-21), 75% had blunt mechanism, 26% were transfused within 6 hours, 3% had 24-hour mortality, and 6% had in-hospital mortality. Median (IQR) syndecan-1 level on admission was significantly higher in injured versus uninjured cohort (44 [21-75] vs. 25 [17-42]; p = 0.04). Admission base deficit was significantly correlated with syndecan-1 level ( r = 0.8, p < 0.001); no association with traumatic brain injury or injury mechanism was seen. Children with elevated syndecan-1 on admission had significantly increased odds of poor outcome; every 10 ng/mL increase in syndecan-1 was associated with 10% increased odds of death or transfusion ( p < 0.001). Transfusion with any blood product was associated with a significant decrease in syndecan-1 from arrival to 24 hours (Δ syndecan-1, -17 [-64 to -5] vs. -8 [-19 to +2]; p < 0001).

CONCLUSION: Elevated admission syndecan-1 level, suggestive of endotheliopathy, was associated with shock and poor outcomes in pediatric trauma. Larger cohort studies are required to fully describe the complexities of trauma-induced coagulopathy and investigate the benefit of therapies targeting endotheliopathy in children.

LEVEL OF EVIDENCE: Prognostic and Epidemiological; Level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Morgan KM, Abou-Khalil E, Gaines BA, et al. Endotheliopathy of trauma in children: The association of syndecan-1 with injury and poor outcomes. J Trauma Acute Care Surg. 2023. PMID: 38079262. doi:10.1097/TA.0000000000004229

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。